Barbara Herlah

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Topics

Circulating Tumor

Breast Cancer Cells

Molecular Docking

Top Venues

Pharmaceuticals (Basel, Switzerland)

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Ilija N Cvijetić, Barbara Herlah, Aleksandar Marinković, Andrej Perdih, Snežana K Bjelogrlić
Phenotypic Discovery of Thiocarbohydrazone with Anticancer Properties and Catalytic Inhibition of Human DNA Topoisomerase IIα. Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
Ilija N Cvijetić, Barbara Herlah, Aleksandar Marinković, Andrej Perdih, Snežana K Bjelogrlić
Phenotypic Discovery of Thiocarbohydrazone with Anticancer Properties and Catalytic Inhibition of Human DNA Topoisomerase IIα. Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
Ilija N Cvijetić, Barbara Herlah, Aleksandar Marinković, Andrej Perdih, Snežana K Bjelogrlić
Phenotypic Discovery of Thiocarbohydrazone with Anticancer Properties and Catalytic Inhibition of Human DNA Topoisomerase IIα. Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
Barbara Herlah, Andrej Hoivik, Luka Jamšek, Katja Valjavec, Norio Yamamoto, Tyuji Hoshino, Krištof Kranjc, Andrej Perdih
Design, Synthesis and Evaluation of Fused Bicyclo[2.2.2]octene as a Potential Core Scaffold for the Non-Covalent Inhibitors of SARS-CoV-2 3CL pro Main Protease. Pharmaceuticals (Basel, Switzerland) 15 (5) (2022)
Matej Janežič, Katja Valjavec, Kaja Bergant Loboda, Barbara Herlah, Iza Ogris, Mirijam Kozorog, Marjetka Podobnik, Simona Golič Grdadolnik, Gerhard Wolber, Andrej Perdih
Dynophore-Based Approach in Virtual Screening: A Case of Human DNA Topoisomerase IIα. International journal of molecular sciences 22 (24) (2021)